Oxford BioMedica's total assets for Q2 2025 were £216.32M, a decrease of -6.62% from the previous quarter. GB:OXB total liabilities were £183.59M for the fiscal quarter, a 7.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.